We are live on
!
Find out more
BCM
Bluefin Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+0.19%
1 Year Est. Return
+18.42%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$313M
AUM Growth
+$180M
(+136%)
Cap. Flow
+$468M
Cap. Flow
% of AUM
149.91%
Top 10 Holdings %
Top 10 Hldgs %
86.39%
Holding
184
New
40
Increased
8
Reduced
11
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRWV
CoreWeave
CRWV
|
+$84.6M |
| 2 |
GTLS.PRB
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
|
+$21.6M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$19.5M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.9M |
| 5 |
Sable Offshore Corp
SOC
|
+$9.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$16.4M |
| 2 |
UnitedHealth
UNH
|
+$13.7M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$6.14M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$5.89M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$4.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.27% |
| 2 | Energy | 5.09% |
| 3 | Communication Services | 2.3% |
| 4 | Healthcare | 1.71% |
| 5 | Real Estate | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amphenol
APH
$207B
| $200K | 0.06% |
+1,617
| New | +$177K |
|
52
CALL
VanEck Gold Miners ETF
GDX
$27.2B
| – | – |
-10,000
| Closed | -$602K |
|
|
PSKY
53
CALL
Paramount Skydance Corp
PSKY
$10.4B
| $177K | 0.06% |
+54,900
| New | +$868K |
|
|
NOTV
54
DELISTED
Inotiv
NOTV
| – | – |
-97,800
| Closed | -$175K |
|
|
KZR
55
DELISTED
Kezar Life Sciences
KZR
| $131K | 0.04% |
+33,610
| New | +$138K |
|
|
CLYM
56
Climb Bio
CLYM
$783M
| $121K | 0.04% |
+59,985
| New | +$111K |
|
57
Neuronetics
STIM
$165M
| $117K | 0.04% |
+42,705
| New | +$152K |
|
58
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.37B
| – | – |
-10,000
| Closed | -$768K |
|
|
FGMCR
59
DELISTED
FG Merger II Corp Rights
FGMCR
| $87.9K | 0.03% |
209,356
-644
| -0.3% | -$167 |
|
60
Acrivon Therapeutics
ACRV
$73.6M
| $76.1K | 0.02% |
+42,039
| New | +$59.1K |
|
61
Atea Pharmaceuticals
AVIR
$412M
| $70.2K | 0.02% |
+24,216
| New | +$82.7K |
|
|
PSKY
62
PUT
Paramount Skydance Corp
PSKY
$10.4B
| $68.9K | 0.02% |
+1,166,100
| New | +$18.4M |
|
|
K
63
PUT
DELISTED
Kellanova
K
| $61.6K | 0.02% |
102,700
+16,400
| +19% | +$1.3M |
|
64
Pliant Therapeutics
PLRX
$64.4M
| – | – |
0
| – | – |
|
65
Adicet Bio
ACET
$75.7M
| $54.2K | 0.02% |
+4,178
| New | +$49.2K |
|
66
Zentalis Pharmaceuticals
ZNTL
$296M
| $47.2K | 0.02% |
+31,266
| New | +$46.9K |
|
|
KDKRW
67
Kodiak AI Warrants
KDKRW
| $41.4K | 0.01% |
38,888
-21,261
| -35% | -$27.7K |
|
68
PUT
Energy Transfer Partners
ET
$70B
| – | – |
-87,500
| Closed | -$1.53M |
|
69
NET Power Inc Warrants
NPWR.WS
$15.4M
| $36.1K | 0.01% |
48,180
+4,900
| +11% | +$3.23K |
|
70
Sutro Biopharma
STRO
$421M
| $30.3K | 0.01% |
+3,493
| New | +$29.7K |
|
71
CALL
CSX Corp
CSX
$93.5B
| $30K | 0.01% |
+150,000
| New | +$5.12M |
|
72
PUT
Brighthouse Financial
BHF
$3.5B
| $23K | 0.01% |
+27,100
| New | +$1.32M |
|
|
ALE
73
PUT
DELISTED
Allete
ALE
| $21.6K | 0.01% |
+72,000
| New | +$4.68M |
|
|
VWAVW
74
VisionWave Holdings Warrant
VWAVW
$1.41M
| $13.3K | ﹤0.01% |
+32,400
| New | +$8.87K |
|
75
Century Therapeutics
IPSC
$357M
| $12K | ﹤0.01% |
+24,018
| New | +$12.9K |
|
Similar funds
PMSA
CFG
BWM
MCA
HAM
SPM
DWM
BIO
Bluefin Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Bluefin Capital Management held 184 positions worth $313M, up 136% from $133M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Bluefin Capital Management deployed $468M of net new capital in Q3 2025, opening 40 new positions and adding to 8 existing holdings. Its largest new stake was Chart Industries 6.75% Series B Preferred Stock: 315,000 shares worth $22.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 13% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $16.4M trimmed.
- Bluefin Capital Management's largest Q3 2025 buy was Chart Industries 6.75% Series B Preferred Stock: 315,000 shares worth $22.4M.
- Bluefin Capital Management added most to CoreWeave in Q3 2025, an estimated $84.6M increase.
- Bluefin Capital Management's biggest Q3 2025 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $16.4M.
- Bluefin Capital Management fully exited UnitedHealth in Q3 2025, selling an estimated $13.7M.
- Bluefin Capital Management's ten largest holdings make up 86% of its $313M portfolio in Q3 2025.
- Bluefin Capital Management opened 40 new positions and closed 120 in Q3 2025.
- Bluefin Capital Management's portfolio value rose 136% quarter-over-quarter to $313M.
Based on Bluefin Capital Management's 13F filing for Q3 2025, filed 29 Apr 2026.